Determinación del poder bactericida de la crema de vancomicina al 0,5 % frente a Staphylococcus aureus

Nodarse Hernández, Rafael; Braña Suárez, Juan Carlos; Palacios Alfonso, Irene.
Rev. cuba. med. mil ; 38(3/4)jul.-dic. 2009.
Artículo en Español | LILACS | ID: lil-629228

Documentos relacionados

  1. Determinación del poder bactericida de la crema de vancomicina al 0.5 por ciento frente a Staphylococcus aureus
  2. Synthesis and structure-activity relationship of berkeleylactone A-derived antibiotics.
  3. [Evaluation of Methicillin Resistance Determination Time for MRSA Using Fully Automated Rapid Identification Susceptibility testing system RAISAS S4].
  4. Antibacterial and Wound-Healing Activities of Statistically Optimized Nitrofurazone- and Lidocaine-Loaded Silica Microspheres by the Box-Behnken Design.
  5. Protein Biomarker Discovery for Methicillin-Sensitive, Heterogeneous Vancomycin-Intermediate and Vancomycin-Intermediate <i>Staphylococcus aureus</i> Strains Using Label-Free Data-Independent Acquisition Proteomics.
  6. Characterization of the phenotypes of methicillin- and vancomycin-susceptible Staphylococcus argenteus after vancomycin passages.
  7. [A retrospective analysis of clinical characteristics and prognostic factors for 152 cases of <i>Staphylococcus aureus</i> bloodstream infection].
  8. Novel nitrofurazone derivatives endowed with antimicrobial activity.
  9. Uncovering the biotechnological capacity of marine and brackish water Planctomycetota.
  10. Descriptive evaluation of patients receiving one-time intravenous vancomycin doses at a large academic medical center emergency department.